28th week of 2009 patent applcation highlights part 42 |
Patent application number | Title | Published |
20090176963 | Organic-acid-based catalyst for production of polylactic acid - Provided is a new organic-acid-based catalyst enabling production of a polyhydroxycarboxylic acid by direct dehydration polycondensation of a hydroxycarboxylic acid such as L-lactic acid, specifically, an organic-acid-based catalyst comprising an amine salt of a sulfonic acid or a phosphine salt of a sulfonic acid for production of polyhydroxycarboxylic acids such as poly-L-lactic acid. | 2009-07-09 |
20090176964 | Stabilized Alpha Helical Peptides and Uses Thereof - Novel polypeptides and methods of making and using the same are described herein. The polypeptides include cross-linking (“hydrocarbon stapling”) moieties to provide a tether between two amino acid moieties, which constrains the secondary structure of the polypeptide. The polypeptides described herein can be used to treat diseases characterized by excessive or inadequate cellular death. | 2009-07-09 |
20090176965 | Sericin Having Improved Antioxidant and Tyrosinase Inhibitive Abilities by Irradiation, and Methods of Making and Using the Same - Disclosed are sericin having improved antioxidant and tyrosinase inhibitory abilities and increased molecular weight by irradiation, which causes a modification of a sericin molecular structure, a preparation method thereof and use of the irradiated sericin in various applications including food products, cosmetics and/or pharmaceutical products and medicines to improve antioxidant ability and/or tyrosinase inhibitory functions. | 2009-07-09 |
20090176966 | Natural IGM Antibodies and Inhibitors Thereof - The invention provides natural IgM antibody inhibitors that may be used to treat various inflammatory diseases or disorders. | 2009-07-09 |
20090176967 | Conjugation of FVII - New FVII polypeptides and FVIIa derivatives, uses of such peptides, and methods of producing these polypeptides and derivatives, are provided. | 2009-07-09 |
20090176968 | Preparation of Triazole Containing Metal Chelating Agents - New chelating agents as well as their tricarbonyl complexes with technetium and rhenium and the use of these compounds in radiodiagnosis and radiotherapy are described. As a peculiarity of this invention, synthesis and coupling of the chelating systems to (bio)molecules is performed simultaneously. The new chelating agents are coupled to substances that accumulate in the diseased/targeted tissue. | 2009-07-09 |
20090176969 | CLONING GENES FROM STREPTOMYCES CYANEOGRISEUS SUBSP. NONCYANOGENUS FOR BIOSYNTHESIS OF ANTIBIOTICS AND METHODS OF USE - The present invention relates to the complete biosynthetic pathway for the formation of the LL-F28249 compounds and, most importantly, the major component LL-F28249α. The purified and isolated nucleic acid molecule encoding the proteins of the biosynthetic pathway, which is isolated from a wild-type or mutant | 2009-07-09 |
20090176970 | Preparation of Thiosugars and Their Use - A process for the preparation of a thiosaccharide represented by Saccharide-S-H wherein Saccharide comprises at least 4 sugar units, comprises subjecting a corresponding compound of the formula (P)Saccharide-S-(P) wherein (P) represents an O- or S-protecting group(s), to Birch reduction. | 2009-07-09 |
20090176971 | Method for Determining Thermal Stability of Collagen or Collagen-Like Peptide - The present invention is a method for determining the thermal stability of a collagen peptide, collagen-like peptide or triple-helix construct with the repeating peptide unit Gly-Xaa | 2009-07-09 |
20090176972 | Novel reactive dyestuff with N,N-dialkylamino bridge group - The present invention relates to a novel reactive dyestuff with an N,N-dialkylamino bridge group, represented by the following formula (I): | 2009-07-09 |
20090176973 | THROMBOPOIETIN MIMETICS - Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative. | 2009-07-09 |
20090176974 | METHOD OF ARALKYLATION OF 4'-HYDROXYL GROUP OF ANTHRACYLINS - A method for the aralkylation of anthracyclins by utilizing an aralkylating agent R | 2009-07-09 |
20090176975 | METHODS AND COMPOSITIONS FOR DETECTING PROMOTER ACTIVITY AND EXPRESSING FUSION PROTEINS - The present invention provides nucleic acid molecules comprising one or more nucleic acid sequences encoding a polypeptide having a detectable activity. The present invention also provides methods of joining such nucleic acid molecules to nucleic acid molecules to be assayed for promoter activity. The present invention also relates to methods of preparing fusion proteins comprising a polypeptide of interest and a polypeptide having a detectable activity. | 2009-07-09 |
20090176976 | NITRILASES - The invention relates to nitrilases and to nucleic acids encoding the nitrilases. In addition methods of designing new nitrilases and method of use thereof are also provided. The nitrilases have increased activity and stability at increased pH and temperature. | 2009-07-09 |
20090176977 | LNA MODIFIED PHOSPHOROTHIOLATED OLIGONUCLEOTIDES - The current invention provides oligonucleotides which comprise a dinucleotide consisting of a 5′ locked nucleic acid (LNA), a phosphorothioate internucleoside linkage bond to a 3′ RNA or RNA analogue. The dinucleotide reduces the strength of hybridization of the oligonucleotide to a complementary nucleic acid target. The modification can be used to modulate hybridisation properties in both single stranded oligonucleotides and in double stranded siRNA complexes, particularly in oligonucleotides where the use of LNA results in excessively strong hybridisation properties. | 2009-07-09 |
20090176978 | QUARTERNIZED AMINO GLUCOSAMINE COMPOUND FOR EXERTING ANTICANCER EFFECT - The present invention relates to the quarternized amino glucosamine, it can exert an anticancer effect via induction of apoptosis in a dose and time dependant manner through which an anticancer treatment effect can be increased. | 2009-07-09 |
20090176979 | PROCESS FOR PRODUCTION OF POLYSACCHARIDE AND/OR MONOSACCHARIDE BY HYDROLYSIS OF DIFFERENT POLYSACCHARIDE - The object is to produce a polysaccharide and/or a monosaccharide efficiently by hydrolyzing a different polysaccharide efficiently. The hydrolysis of a polysaccharide is an important means for producing a monosaccharide that can be used as a starting material for the production of ethanol, the solubilization of a water-insoluble polysaccharide, and the production of a useful water-soluble low-polymeric saccharide or the like. For achieving the object, a polysaccharide to be hydrolyzed is reacted with water in the presence of a carbonaceous material having sulfonic acid group therein to cause the hydrolysis of the polysaccharide to be hydrolyzed, thereby producing a other polysaccharide and/or a monosaccharide. | 2009-07-09 |
20090176980 | 3-Substituted-6-Aryl Pyridines - 3-substituted-6-aryl pyridines of Formula I are provided: | 2009-07-09 |
20090176981 | Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses - The present invention provides stereoisomers and stereoisomeric mixtures of 3-amino carbonyl-bicycloheptene-2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers. | 2009-07-09 |
20090176982 | PROCESS FOR DRYING MELAMINE - A process is described for drying melamine wet cakes, comprising the steps of: a) providing a turbo-dryer (T) comprising a cylindrical tubular body ( | 2009-07-09 |
20090176983 | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal - The present invention provides a novel crystalline form of Tenofovir disoproxil fumarate (Tenofovir DF), designated Co-crystal TDFA 2:1, methods for the preparation thereof and its use in pharmaceutical applications, in particular in anti-HIV medicaments. The crystalline form TDFA 2:1 can be used in combination with other anti-HIV medicaments such as Efavirenz, Emtricitabine, Ritonavir and/or TMC114. | 2009-07-09 |
20090176984 | Isotopically Enriched N-Substituted Piperazine Acetic Acids And Methods For The Preparation Thereof - In some embodiments, this invention pertains to isotopically enriched N-substituted piperazine acetic acids. In some embodiments, this invention pertains to methods for the preparation of isotopically enriched N-substituted piperazine acetic acids. | 2009-07-09 |
20090176985 | METHOD FOR CONVERTING PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIIMIDES INTO A FORM SUITABLE FOR USE AS A FLUORESCENT DYE - A process for converting perylene-3,4:9,10-tetracarboximides of the general formula I | 2009-07-09 |
20090176986 | Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist Intermediate - An efficient syntheses for the preparation of the intermediate 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine dihydrochloride, and other salt forms of 2-oxo-1-(4-piperidinyl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine. | 2009-07-09 |
20090176987 | CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION - A method for producing a drug substance of crystalline pitavastatin calcium excellent in stability, is presented. In the production of a compound (pitavastatin calcium) represented by the formula (1): | 2009-07-09 |
20090176988 | Preparation and Use of Magnesium Amides - The present application relates to mixed Mg/Li amides of the general formula R1R2N—Mg(NR3R4)mX,m zLiY (II) wherein R | 2009-07-09 |
20090176989 | PROCESSES FOR PRODUCING CYCLOALKYLCARBOXAMIDO-PYRIDINE BENZOIC ACIDS - The present invention relates to a process of providing the 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1). | 2009-07-09 |
20090176990 | PROCESS FOR PRODUCING NITROGUANIDINE DERIVATIVES - Disclosed is an improved process for producing nitroguanidine derivatives represented by the following general formula (3), which has an insecticidal activity, or a salt thereof. Specifically, disclosed is a process for producing nitroguanidine derivatives represented by the following general formula (3) or a salt thereof, in which nitroisourea derivatives represented by the following general formula (1) or a salt thereof and compounds represented by the following general formula (2) or a salt thereof are reacted in the presence of a base in an aqueous solution wherein an inorganic salt is dissolved at not less than 50% of its saturated solubility, | 2009-07-09 |
20090176991 | BENZAMIDE GLUCOKINASE ACTIVATORS - The present invention relates to N-heteroaryl-benzamides of the formula (I), pharmaceutical compositions comprising the same, and methods of using the same. The N-heteroaryl-benzamides are useful as glucokinase activators. | 2009-07-09 |
20090176992 | PROCESS FOR THE PREPARATION OF HIGHLY OPTICAL PURE CARVEDILOL - The present invention relates to a process for the efficient preparation of highly optical pure chiral carvedilol. According to the present invention, a chiral oxazolidin-2-one or oxazolidin-2-thione having formula 2, produced from the reaction of N-protected 2-(2-methoxyphenoxy)ethylamine with a chiral glycidol derivative is used as a key intermediate for the preparation of the chiral carvedilol. Specifically, the process for the preparation of the chiral carvedilol comprises a) reacting a compound of formula 2 with a halogenation agent, a sulfonation agent or a mitsunobu reagent to activate a hydroxyl group of the compound of formula 2, followed by nucleophilic substitution reaction with 9H-4-hydroxy carbazole to produce a compound of formula 7, and b) subjecting the obtained compound of formula 7 to a deprotection reaction in a presence of an inorganic base to produce the targeted chiral carvedilol. The process of the present invention can be accomplished in a mild condition. The process neither requires any extraordinary purification procedure, nor involves decrease of optical purity. Therefore, the process of the present invention provides highly optical pure chiral carvedilol in simple and efficient manner. | 2009-07-09 |
20090176993 | Calcium receptor active compounds - A novel calcium receptor active compound having the formula is provided: | 2009-07-09 |
20090176994 | ORGANIC PHOTOVOLTAIC DEVICES COMPRISING FULLERENES AND DERIVATIVES THEREOF AND IMPROVED METHODS OF MAKING FULLERENE DERIVATIVES - Improved methods of fullerene derivative production including use of less solvent, or elimination of solvent, as well as use of shorter reaction times and higher reaction temperatures. Methods useful for production of bis-, tris-, tetra-, penta-, and hexa-fullerene derivatives. Indene is a preferred derivative. The derivatives used in active layers for solar cell applications. | 2009-07-09 |
20090176995 | Soluble fullerene derivatives - Disclosed are soluble diarylmethanofullerene derivatives that are effective as acceptors for organic thin-film solar batteries. They help to constitute effective organic thin-film solar batteries. | 2009-07-09 |
20090176996 | PROCESS FOR THE PREPARATION OF SULFAMIDE DERIVATIVES - The present invention is directed to novel processes for the preparation of sulfamide derivatves, useful in the treatment of epilepsy and related disorders. | 2009-07-09 |
20090176997 | Process for producing vinylene carbonate - The present invention relates to the industrial production of vinylene carbonate (VC) by eliminating hydrogen chloride from chloroethylene glycol carbonate (CGC) or solid catalysts in the gas phase, the reaction being carried out over a catalyst bed agitated by thorough mixing. | 2009-07-09 |
20090176998 | Process for the manufacture of chroman derivatives, especially alpha-tocopherol and alka-noates thereof - The present invention relates to novel processes for the manufacture of chroman derivatives such as α-tocopherol (TCP) and alkanoates thereof, especially α-tocopheryl acetate (TCPA), whereby at least one step of the processes is carried out in the presence of a Lewis acid or a mixture of a Lewis acid with a Bronsted acid as the catalyst under pressure, preferably at an absolute pressure of at least 1.1 bar. | 2009-07-09 |
20090176999 | Process for producing hexahydrofurofuranol derivative - The present invention provides; a process for producing a compound (IV) comprising a step of reacting a compound (I) with a compound (II) in the presence of an optionally substituted cyclic secondary amine to obtain a compound (III) and a step of sequentially or simultaneously eliminating R | 2009-07-09 |
20090177000 | ALKYLENE OXIDE CATALYST AND USE THEREOF - A supported silver catalyst and use thereof in a process for producing an alkylene oxide, such as ethylene oxide, by the direct oxidation of an alkylene with oxygen or an oxygen-containing gas, wherein the catalyst provides improved stability and improved resilience to reactor upsets and timely recovery to substantially pre-upset levels of catalyst activity and/or efficiency. In some embodiments, the catalyst also exhibits improved activity. A catalyst capable of producing ethylene oxide at a selectivity of at least 87 percent while achieving a work rate of at least 184 kg/h/m3 at a temperature of no greater than 235° C. when operated in a process where the inlet feed to a reactor containing the catalyst comprises ethylene, oxygen, and carbon dioxide, wherein the concentration of carbon dioxide in the inlet feed is greater than or equal to 2 mole percent. | 2009-07-09 |
20090177001 | NOVEL PROCESS AND INTERMEDIATES - The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of steroidal 17β-carboxylic thioates, such as fluticasone propionate I, using soluble mixed fluorides to introduce fluorine by displacing an appropriate leaving group X in compounds II resulting in selective and controlled fluorination. The present invention also relates to intermediates II and their preparation. | 2009-07-09 |
20090177002 | Method For Preparing Indene Derivatives, And Intermediates For Preparation Of Derivatives - Indene derivatives that are utilizable as intermediates in the synthesis of the vitamin D | 2009-07-09 |
20090177003 | Process for obtaining halogenated monoorganoxysilanes which can be used in particular as sysnthesis intermediates - The invention concerns the preparation of halogenated monoorganoxysilanes, of formula (I), | 2009-07-09 |
20090177004 | PROCESS OF MAKING 3-AMINOPENTANENITRILE - A process for making 3-aminopentanenitrile from a crude 2-pentenenitrile (“crude 2PN”) comprising 2-pentenenitrile, 2-methyl-2-butenenitrile, and 2-methyl-3-butenenitrile includes contacting the crude 2PN with an ammonia-containing fluid and water. The ammonia-containing fluid can include at least one reactant selected from the group consisting of ammonia, aqueous ammonia, and ammonium hydroxide. | 2009-07-09 |
20090177005 | Method For Producing 2-(chloromethyl)penylacetic acid derivatives - A process for preparing 2-(chloromethyl)phenylacetic acid derivatives of the formula I, | 2009-07-09 |
20090177006 | Process for the Production of Acetic Acid - A process for the production of acetic acid by carbonylating methanol and/or a reactive derivative thereof with carbon monoxide in the presence of an iridium promoted carbonylation catalyst wherein the promoters are ruthenium and at least one of niobium and tantalum. | 2009-07-09 |
20090177007 | PROCESS FOR PRODUCING CARBOXYLIC ACID ANHYDRIDES - The present invention relates to a process for producing carboxylic acid anhydrides, in which a carboxylic acid ester, derived from an alcohol and a carboxylic acid, and carbon monoxide containing a small amount of hydrogen are used as raw materials and subjected to a carbonylation reaction in a liquid reaction medium in the presence of a Group VIII B catalyst to produce a carboxylic acid anhydride. The reaction medium comprises the Group VIII B catalyst, an organic halide, the carboxylic acid ester, an alkali metal salt, at least one organic promoter, the carboxylic acid anhydride and the carboxylic acid, wherein the organic promoter is selected from at least one of the following structural forms (I), (II) and (III). According to the process of the present invention, the reaction rate of the carbonylation reaction is increased by the use of the specified organic promoters. | 2009-07-09 |
20090177008 | NOVEL PROCESS FOR SYNTHESIS OF ITOPRIDE AND ITS NOVEL INTERMEDIATE N-(4-HYDROXYBENZYL)- 3,4-DIMETHOXYBENZAMIDE - The present invention relates to a novel and improved process for the preparation of N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide—known as Itopride, via a novel intermediate N-(4˜hydroxybenzyl)-3,4-dimethoxybenzamide. | 2009-07-09 |
20090177009 | PROCESS OF MAKING SERTRALINE FORM II - The present invention discloses novel and improved processes for preparation of sertraline hydrochloride crystalline form II. Thus, for example, sertraline free base is dissolved in isoamyl alcohol at 25-30° C., pH of the mass is adjusted to 2.0 with conc. hydrochloric acid (36%) at 25-30° C. and then stirred for 14 hours at 25-30° C. Filtered the solid and dried at 65° C. for 4 hours to give sertraline hydrochloride crystalline form II. The present invention also provides a novel process for preparation of sertraline hydrochloride crystalline form I. | 2009-07-09 |
20090177010 | PROCESS OF MAKING SERTRALINE FORM I - The present invention discloses novel and improved processes for preparation of sertraline hydrochloride crystalline form II. Thus, for example, sertraline free base is dissolved in isoamyl alcohol at 25-30° C., pH of the mass is adjusted to 2.0 with conc. hydrochloric acid (36%) at 25-30° C. and then stirred for 14 hours at 25-30° C. Filtered the solid and dried at 65° C. for 4 hours to give sertraline hydrochloride crystalline form II. The present invention also provides a novel process for preparation of sertraline hydrochloride crystalline form I. | 2009-07-09 |
20090177011 | PROCESS FOR THE PRODUCTION OF ANILINES - The present invention relates to a process for the preparation of compounds of formula (I) wherein R | 2009-07-09 |
20090177012 | PROCESS FOR PRODUCING ALPHA, ALPHA-DIFLUOROAMINE - A process for producing an α,α-difluoroamine which comprises using hydrogen fluoride and a Lewis base in specific amounts in the halogen-fluorine exchange reaction using an α,α-dihaloamine as the substrate. The process can be industrially applied, enables to obtain the object compound in a short time at a great yield and can be conducted easily with excellent productivity. | 2009-07-09 |
20090177013 | Polyetheramine Production Method - The invention relates to a method for producing amines of formula (1), | 2009-07-09 |
20090177014 | Process for Preparing 4,4' Difluorobenzophenone - Process for preparing 4,4′-difluorobenzophenone, characterized in that, in a first step, fluorobenzene is reacted with formaldehyde under catalysis by organic sulphonic acids to give difluorodiphenylmethane, the product obtained is isolated, and, in a second step, oxidized with nitric acid to give 4,4′-difluorobenzophenone. 4,4′-Difluorobenzophenone (4,4′-DFBP) is the central starting material for the preparation of aromatic polyether ketones. | 2009-07-09 |
20090177015 | Production Method of Acrolein - The present invention has an object to provide a production method of acrolein capable of producing acrolein with suppressing the yield change with time. The production method of the invention is that glycerin is dehydrated under coexistence with a catalyst having crystalline metallosilicates containing at least one kind of T atoms and 15% by mass or less of a binder, and the Si atoms to T atoms ratio (Si/T) of the catalyst is 800 or less. | 2009-07-09 |
20090177016 | CATALYST AND PROCESS USING THE CATALYST - A catalyst which comprises a carrier and silver deposited on the carrier, which carrier has a surface area of at least 1 m | 2009-07-09 |
20090177017 | Precursors to Fluoroalkanol-Containing Olefin Monomers, and Associated Methods of Synthesis and Use - The invention provides alkene fluoroalkanol and fluorinated polyol precursors to fluoroalkanol-substituted α,β-unsaturated esters. The fluoroalkanol-substituted α,β-unsaturated esters are olefins that can be readily polymerized to provide fluoroalkanol-substituted polymers useful in lithographic photoresist compositions. Also provided are methods for synthesizing the alkene fluoroalkanol and fluorinated polyol precursors. | 2009-07-09 |
20090177018 | Process for Producing Product of Hydrogenolysis of Polyhydric Alcohol - The present invention relates to a process for producing hydrogenolysis products of polyhydric alcohols with a high selectivity as well as hydrogenolysis catalysts used in the hydrogenolysis reaction. The present invention provides a process for producing a hydrogenolysis product of a polyhydric alcohol which includes the step of reacting the polyhydric alcohol with hydrogen in the presence of a catalyst containing (A) a platinum-supporting heterogeneous catalyst component and (B) at least one catalyst component selected from the group consisting of tungsten components and molybdenum components, or in the presence of a catalyst containing a heterogeneous catalyst component formed by supporting (A′) platinum and the above catalyst component (B), on a common carrier; as well as catalysts for hydrogenolysis of polyhydric alcohols. | 2009-07-09 |
20090177019 | PROCESS FOR PRODUCING ADAMANTANE - Provided is a method for production of adamantane which enables producing a high-purity adamantane at low cost and with high efficiency by using effectively trimethylenenorbornane contained in a heavy raffinate heavy and having conventionally been no use other than fuels and the like, and which enables alleviating poisoning of a catalyst used in isomerization and corrosion of devices, whereby an industrially advantageous adamantane can be produced. In addition, the process for producing adamantane including an isomerization process of isomerizing trimethylenenorbornane contained in a raffinate obtained from a platfinate is characterized by including a water-washing removal process of removing sulfolane in a trimethylenenorbornane concentrate to be supplied in the isomerization process by water-washing. | 2009-07-09 |
20090177020 | Process for Production of Aromatic Hydrocarbons - The present invention provides a process for producing aromatic hydrocarbons at a sufficiently high yield, from a light hydrocarbon containing mainly hydrocarbons having 7 or fewer carbon atoms. The process of the present invention comprises bringing a feedstock containing mainly light hydrocarbons having 2 to 7 carbon atoms into contact with a catalyst composition comprising at least a gallium-containing crystalline aluminosilicate wherein a reaction step for converting the feedstock to aromatic hydrocarbons comprises at least two or more reaction layers formed of the catalyst composition, arranged in series and heating means arranged either between or in the reaction layers, the amount of the catalyst in the first stage reaction layer is 30 percent by volume or less of the total catalyst volume, and/or the yield of the aromatics in the product outflowing from the first reaction layer is from 0.5 to 30 percent by mass. | 2009-07-09 |
20090177021 | Aromatic Transalkylation Using A Modifed LZ-210 Zeolite - A process for converting polyalkylaromatics to monoalkylaromatics, particularly cumene, in the presence of a modified LZ-210 zeolite catalyst is disclosed. The process attains greater selectivity, reduced formation of undesired byproducts, and increased activity. | 2009-07-09 |
20090177022 | Cracking tube having helical fins - A cracking tube ( | 2009-07-09 |
20090177023 | FILTRATION TRAY FOR FIXED BED REACTOR WITH A CO-CURRENT DOWN-FLOW OF GAS AND LIQUID - The device described in the present invention can trap plugging particles contained in the liquid feed supplying a reactor functioning in gas and liquid co-current down-flow mode using a specific distributor tray comprising a filtration medium. | 2009-07-09 |
20090177024 | SELF-REMEDIATING FILTER - Self-remediating filters have a heavy metal remediation agent contained in a water-soluble, polymeric material, adjacent to or disposed in a filter medium. A method of remediating conventional, heavy metal-contaminated filters is also provided, wherein a contaminated filter is allowed to contact an aqueous slurry of a heavy metal remediation agent. | 2009-07-09 |
20090177025 | Mercury Contamination Extraction - Mercury is removed from contaminated waste by firstly applying a sulfur reagent to the waste. Mercury in the waste is then permitted to migrate to the reagent and is stabilized in a mercury sulfide compound. The stable compound may then be removed from the waste which itself remains in situ following mercury removal therefrom. | 2009-07-09 |
20090177027 | PARTIALLY ERODABLE SYSTEMS FOR TREATMENT OF OBSTRUCTIVE SLEEP APNEA - The invention relates to devices and methods for reforming tissue surrounding the airway of a subject suffering from obstructive sleep apnea so as to open the airway and alleviate the occurrence of apneic events. Devices comprise a combination of resiliently deformable material and bioerodible material. The deformable portion of the device has a preferred shape that corresponds to the desired final shape of the device once placed in an airway. In making a transplant-ready device, however, the deformable portion is placed into a deformed shape and constrained in that shape by the bioerodible material. After implantation, the device gradually assumes the preferred shape as the constraining bioerodible material erodes. As the device gradually reforms toward the preferred shape, it reforms the tissue into the therapeutically desirable configuration. The gradual nature of the shape change generally stabilizes the device in the tissue, and supports tissue reforming into a stable configuration. | 2009-07-09 |
20090177028 | Non-blood contact cardiac compression device, for augmentation of cardiac function by timed cyclic tensioning of elastic cords in an epicardial location - One embodiment of a device to augment the pumping function of a weakened heart. A set of connectors with elastic properties are positioned immediately proximate to the outer surface of the heart. Each of the elastic connectors is attached at one end to a circumferential band firmly attached to the exterior surface of the heart at around the level of the atrioventricular groove, an anatomical feature of the heart. At the other end, each of said elastic connectors is attached to a cap attached firmly to the heart exterior of the heart at the anatomical apex. A mechanism places the elastic connectors alternatively under tension (stretch) then shortening (relaxation). When the elastic connectors are stretched they draw the apex and circumferential band together, resulting in external compression of the heart. This movement causes the internal volume of the cardiac ventricles to be reduced, thereby encouraging expulsion of the blood contents of the ventricles to be expelled. This action will be timed so as to augment the natural cardiac contraction, and thereby improve its pumping function. | 2009-07-09 |
20090177030 | ENDOSCOPIC INCISION SYSTEM - An endoscopic incision system includes: an endoscope; a cylindrical member for covering at least a distal end of an insertion section of the endoscope; and at least an incision section for incising a living tissue, the incision section being provided to a distal end of the cylindrical member and being capable of being exposed from the distal end of the cylindrical member outwardly. In this configuration, the radially expanding incision section will not be twisted or bent, and the incision section prevented from inadvertent fall-off can maintain the desirable shape when it is operated and rotated. | 2009-07-09 |
20090177031 | MEDICAL SYSTEMS, DEVICES AND METHODS FOR ENDOSCOPICALLY SUTURING PERFORATIONS - Medical systems, devices and methods are disclosed for suturing a perforation in tissue, that may be employed endoscopically and/or laparoscopically, and that offer simple, reliable and controllable placement of suture around a perforation for complete closure thereof. One embodiment of the medical system generally includes an endoscope, an endcap, a needle, a suture, and first and second grip systems configured for relative translation to selectively pass the needle between the first and second grip systems. | 2009-07-09 |
20090177032 | METHOD AND APPARATUS FOR MAGNETICALLY CONTROLLING ENDOSCOPES IN BODY LUMENS AND CAVITIES - A magnetically navigable endoscope system includes an endoscope having a proximal end and a distal end, the distal end having a magnetic body; a component which transmits an image, associated with the distal end; a display component for displaying the image; a magnetic field generating apparatus for generating a magnetic field to orient the magnetic body and thus the distal end of the endoscope; and a controller coordinated with the display for controlling the magnetic field generating apparatus to selectively change the magnetic field to change the orientation of the magnetic body and thus the distal end of the endoscope. | 2009-07-09 |
20090177033 | CAPSULE CAMERA WITH VARIABLE ILLUMINATION OF THE SURROUNDING TISSUE - The application relates to an ingestible capsule and method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being. The capsule comprises an image sensor; a lens system for focusing images onto the image sensor; at least one light source for illumination of the tissue area of interest, the at least one light source optionally being capable of providing optical therapeutic treatment to the diseased areas; a variable lens system located in front of the at least one light source, wherein the variable lens system comprises beam steering means and focusing means for directing and focusing the light beams from the at least one light source onto the diseased tissue areas, a control unit in communication with the image sensor, the at least one light source, and variable lens system, a power source for powering the image sensor, the at least one light source and the control unit; and a non-digestible, transparent outer protective shell configured to pass through the gastrointestinal tract, housing within the image sensor, the lens system, the at least one light source, the variable lens system, the control unit and the power source. | 2009-07-09 |
20090177034 | ENDOSCOPE SYSTEM - An endoscope system of the invention includes an elongated insertion portion; an image pickup portion provided with an objective optical system having an optical axis diagonal to a longitudinal axis direction of the insertion portion and that picks up an image of a subject present in a field of view of the objective optical system and can rotate around the longitudinal axis of the insertion portion; a rotation angle detection portion that detects a rotation angle of the image pickup portion; an image pickup control portion that can have images of a plurality of subjects picked up while the image pickup portion makes one rotation by controlling the image pickup portion on the basis of the rotation angle detected by the rotation angle detection portion; and a signal processing portion that carries out signal processing for having each image of the plurality of subjects displayed on one display portion. | 2009-07-09 |
20090177035 | ENDOSCOPE INSTRUMENTS SYSTEMS AND METHODS FOR CLOSED CHEST EPICARDIAL ABLATION - Endoscopic surgical instruments, lens elements and methods of treating or ablating tissue such as epicardial surfaces of cardiac tissue. An endoscopic surgical instrument includes an elongate shaft, a lens attached to the distal end of the shaft, and a coupling element extending from or attached to the lens. The distal end of the lens can protrude through the coupling element so that an ablation element, such as a flexible microwave ablation element, held by the coupling element is in the line of sight of the lens. Embodiments can be used to selectively ablate epicardial surfaces to treat atrial fibrillation and form more complete lesions around pulmonary veins without severing or penetrating a pericardial reflection near the superior vena cava. | 2009-07-09 |
20090177036 | In-Body Position Detecting System - A medical capsule device ( | 2009-07-09 |
20090177037 | REMOTE CONTROL OF MEDICAL DEVICES USING REAL TIME LOCATION DATA - A method of determining the quality of contact between a remotely navigated medical device and a cyclically moving anatomical structure includes measuring movement of the device, and processing the measured movement of the device to determine the contact between the device and the moving anatomical structure. | 2009-07-09 |
20090177038 | ELECTRONIC ENDOSCOPE - A connector includes a cable attachment ring that fits onto a signal cable, a circuit board attachment part that catches a circuit board, and a connecting pillar that connects the cable attachment ring and the circuit board attachment part. The cable attachment ring is detachable from the signal cable, and the circuit board attachment part is detachable from the circuit board. | 2009-07-09 |
20090177039 | Shaft Rotating Device - A shaft rotating device for rotating a shaft of a medical instrument about its longitudinal axis relative to a handle of the medical instrument comprises an operating element for rotating the shaft. The operating element is arranged at a proximal portion of the shaft and it is in driving connection with the shaft such that the shaft is rotatable relative to the handle against frictional forces. The shaft rotating device further comprises a frictional element with a surface. The surface of the frictional element is in frictional contact with the surface of a counterpart for keeping the shaft and the handle rotationally stationary with respect to each other and movable against the frictional forces. The operating element and the frictional element are in operational connection with respect to one another such that a torque applied to the operating element decreases the frictional forces. The shaft and the frictional element are in operational connection with one another such that a torque applied to a distal portion of the shaft increases the frictional forces. | 2009-07-09 |
20090177040 | Instrument shaft - A shaft for a flexible endoscopic instrument is provided in which the shaft comprises a generally tubular frame member, the tubular frame member providing the shaft with at least one flexible section along the length of the shaft, the flexible section having a greater flexibility than at least one other section of the shaft. The flexible section of the shaft has a proximal end and a distal end, and is provided with first and second series of slots, the slots of the first series alternating with the slots of the second series to form an offset pattern of staggered slots in the frame member to provide the different stiffness properties. Each of the slots in a selected one of either the first or second series of slots is of a different length as compared to other slots in that series of slots, the slots in the selected series varying in length according to a predetermined progression, such that the flexible section is designed to deflect in a controlled and predetermined manner. | 2009-07-09 |
20090177041 | ARTICULATING SURGICAL DEVICE AND METHOD OF USE - Various embodiments of an elongate surgical device configured to travel along a tortuous body lumen to a surgical site are provided herein. In one embodiment, the device can include a tensioning element extending through a channel formed along a length of the device and the tensioning element can translate an articulation force to the working end of the device. During such articulation of the device, a portion of the channel can be configured to allow the tensioning element to exit the channel and move away from a longitudinal axis of the device thereby optimizing a mechanical advantage relative to the distal end of the device and thus maximizing the force capable of being delivered thereto. Additionally, various embodiments of a method for articulating a working end of an elongate surgical device are provided herein. | 2009-07-09 |
20090177042 | Color image acquisition with scanning laser beam devices - An apparatus may include an interface to allow a scanning beam device to be coupled. The apparatus may include at least four lasers optically coupled with the interface. Each of the at least four lasers may provide a different wavelength visible spectrum light to the scanning beam device through the interface. An actuator driver of the apparatus may be electrically coupled with the interface. The actuator driver may provide actuator drive signals to the scanning beam device through the interface. The actuator drive signals may be operable to cause the scanning beam device to scan a beam of the different wavelength lights over a surface. An image generation unit of the apparatus may generate an image of the surface. The image may be generated based, at least in part, on light from the beam that has been reflected from the surface and detected by at least one photodetector. | 2009-07-09 |
20090177043 | Objective Optical System for Endoscopes and Endoscope System Using the Same - An objective optical system for endoscopes is provided for the purpose of carrying out a fluorescence observation. At least two excitation light cutoff filters in which the transmittance of excitation light in its wavelength band is 0.1% or less are arranged and an optical element with power is interposed between arbitrary two of the excitation light cutoff filters. Whereby, the leakage of the excitation light caused by oblique incidence on the excitation light cutoff filter can be effectively prevented and even the feeble fluorescent light can be observed without flare with respect to the excitation light. | 2009-07-09 |
20090177044 | DISPOSABLE SPECULUM - A disposable plastic vaginal speculum constructed for heavy duty use and/or for long duration gynecological procedures including intrauterine device insertion and vaginal surgical procedures. The hinge region of the speculum, as well as other regions, are reinforced so that the speculum can bear forces of a magnitude normally bearable only by metal vaginal specula. | 2009-07-09 |
20090177045 | System and method for data aggregation and prioritization - A computer enabled system and method aggregates data describing a particular subject. The data is then divided into a predetermined group of categories which are graphically displayed according to a predetermined pattern. Distortions in the data or anomalies in the data are made visually apparent. Associated with the display is a prioritized array of interventions recommended in response to the distortions in the data or anomalies appearing in the data. | 2009-07-09 |
20090177046 | Patient Monitoring and Treatment Medical Signal Interface System - A medical signal interface device bidirectionally conveys signals between a patient and patient monitoring devices. The device comprises a bidirectional electrical signal interface that receives and buffers patient parameter monitoring signals received from a patient via patient attached leads and outputs treatment related signals used in applying invasive or non-invasive treatment to a patient. A bidirectional electrical signal processor operates in response to commands received from a control processor and is coupled to the electrical signal interface, for processing received patient parameter monitoring signals using filtering and amplification to provide processed patient monitoring signals for output to at least one patient monitoring device. The bidirectional electrical signal processor processes the treatment related signals for output by buffering the treatment related signals for output to a patient. A control processor provides data representing the commands in response to at least one of, (a) predetermined configuration data and (b) deriving data representing the commands from data entered by a user via a displayed user interface image. | 2009-07-09 |
20090177047 | HEALTH WELLNESS MODELER - A system for modeling the wellness of an individual. The system can include one or more electronic data processing elements. Additionally, the system can include a population profile integrator configured to execute on the electronic data processing element for integrating pre-determined health indicators with statistically-valid health data derived from a sample population. The system also can include an individual health profile comparator configured to execute on the electronic data processing element for comparing the integrated health indicators and health data to individual-specific health data. The system further can include a wellness modeler configured to execute on the electronic data processing element for generating a wellness assessment of an individual based on the comparison of the integrated health indicators and health data to the individual-specific health data. Optionally, the system can also include a re-calculation and projection tool configured to execute on the electronic data processing element for projecting probabilistic health results based on simulated variations of values of the individual-specific health data. | 2009-07-09 |
20090177048 | MINIATURE, WIRELESS APPARATUS FOR PROCESSING PHYSIOLOGICAL SIGNALS AND USE THEREOF - The present invention provides an apparatus and method for processing plural of physiological signal input from external sensors are received by the signal-receiving element in a synchronized pattern. | 2009-07-09 |
20090177049 | Piezoelectric film - A method for producing a biocompatible material of the formula Na | 2009-07-09 |
20090177050 | INTEGRATED MEDICAL IMAGING SYSTEMS - An image acquisition system operable to obtain an image of at least a portion of a body, includes an imaging system including at least one energy sensor to measure energy from the body, an image creating system adapted to create an image based at least in part from a signal from the at least one energy sensor, an image display in operative connection with the image creating system and a user interface in operative connection with the image creating system. The image acquisition system further includes a fluid injector system including at least one source of a first fluid, a pressurizing system in operative connection with the source of the first fluid, and a user interface in operative connection with the pressurizing system. The imaging system and the injector system are operatively integrated in at least two of the following and/or other aspects: physical connection, data input via at least one common user interface, displaying of information via at least one common display, electrical connection to at least one common power conditioning system, receipt of common data from at least one patient physiological sensor, at least one common communication port to at least one information system, and a common control system (including any common portion of a control system). | 2009-07-09 |
20090177051 | SYSTEMS AND METHODS FOR PROVIDING SUB-DRESSING WOUND ANALYSIS AND THERAPY - Thus, systems and methods providing sub-dressing wound analysis and therapy are provided. One embodiment of the invention may include a treatment system including a wound dressing comprising perforations. The system may also include a light receptor and an excitation light source. When the wound dressing is deployed on a wound, the light source may provide light that propagates through the wound and is detectable via the perforations. Furthermore, the light receptor may be configured to receive the transmitted light. The transmitted light may include information relating to the viability of tissue within the wound. | 2009-07-09 |
20090177052 | Methods of using raman spectral information in determining analyte concentrations - A non-invasive method of determining the concentration of an analyte uses Raman spectral information. A high-intensity, narrow band of light ( | 2009-07-09 |
20090177053 | Coaxial LED Light Sources - An emitter device may include at least two emitters, such as LEDs. The coaxially disposed emitters may emit light in substantially the same area so that no apparent distance is perceived between individual emitters, as in emitter devices in which the emitters are disposed adjacent one another. The coaxially disposed emitters may include emitters suitable for pulse oximetry and/or water fraction measurements, for example. | 2009-07-09 |
20090177054 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177055 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177056 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177057 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177058 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177059 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177060 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177061 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177062 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177063 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |
20090177064 | Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor. | 2009-07-09 |